Alcolear holds three US patents for its unique dual-enzyme supplement and is seeking patents in key areas around the globe. These patents cover a composition containing two enzymes working together to efficiently break down alcohol in the human body. The first enzyme converts alcohol into a harmful metabolite, which is then converted by the second enzyme into a harmless form that can be excreted from the body. The specific ratio of these enzymes in the composition is crucial for avoiding elevated levels of the intermediate harmful metabolite, ensuring optimal alcohol metabolism and minimising negative symptoms.